The Quantellect read.As of Nov 19, 2026, 11 active firms cover Booz Allen Hamilton Holding: 3 rate it Buy or better, 5 sit at Neutral, and 3 rate it Sell or worse, a neutral consensus. Targets range widely, $65.00 to $140.00 (about 2.2x), a sign of real disagreement on valuation. The average target of $86.55 sits 3% above the current $84.05. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 2 to 3 over recent months. On the fundamentals, the Street sees revenue growth near 2% next year, consensus EPS building from about $1.57 next quarter toward $6.75 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 active firms
Neutral
Strong Buy00%
Buy327%
Neutral545%
Sell327%
Strong Sell00%
Based on 11 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$86.55
+3.0% upside
Average target across 11 active firms as of Nov 19, 2026 vs $84.05 current
Highest Target$140.00
Average Target$86.55
Lowest Target$65.00
Detailed analyst forecasts for BAH
Showing 1–12 of 12 named analysts shown · 11 active firms in the rating projection
As of Nov 19, 2026, 3 of 11 active firms rate BAH a Buy (5 Neutral, 3 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
BAH EPS & revenue forecast
EPS · NEXT QUARTER
$1.57
Range $1.47 – $1.66 · 13 analysts · -12% YoY
Next period, 13 analysts expect Booz Allen Hamilton Holding to earn $1.57 a share (range $1.47 – $1.66), versus $1.78 a year earlier. Full-year consensus is $6.62, growing to $6.75 the year after.
REVENUE · NEXT QUARTER
$3.0B
Range $2.9B – $3.1B · 13 analysts · -2% YoY
Revenue is expected to reach $3.0B (range $2.9B – $3.1B), -2.0% year-over-year. Full-year consensus is $11.4B, rising to $11.9B next year.
Top analysts covering Booz Allen Hamilton Holding
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BAH.
#1
Ronald Epstein
B of A Securities · Rank #47
Sell
$68.00-19.1% to target
Overall win rate
56%
+ Follow
#2
Matthew Akers
Wells Fargo · Rank #369
Buy
$135.00+60.6% to target
Overall win rate
40%
+ Follow
#3
Noah Poponak
Goldman Sachs · Rank #416
Sell
$63.00-25.0% to target
Overall win rate
37%
+ Follow
#4
Brian Gesuale
Raymond James · Rank #439
Neutral
No targeton BAH
Overall win rate
34%
+ Follow
#5
Tobey Sommer
Truist Securities · Rank #445
Buy
$85.00+1.1% to target
Overall win rate
36%
+ Follow
BAH stock forecast FAQ
What is BAH's average 12-month price target?+
The 11 active firms with a live target average $86.55 for Booz Allen Hamilton Holding over the next 12 months, ranging from a $140.00 high to a $65.00 low, as of Nov 19, 2026.
Is BAH stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 11 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 5 rate it Neutral, and 3 rate it Sell or Strong Sell.
What are the highest and lowest price targets for BAH?+
The Street-high target is $140.00 (Cantor Fitzgerald), and the Street-low is $65.00 (Goldman Sachs). The average of all 11 active-firm targets is $86.55.
How many active Wall Street firms cover BAH?+
11 active firms have a recognized rating on Booz Allen Hamilton Holding as of Nov 19, 2026, and 11 active firms carry a live 12-month price target.
Who is the most accurate analyst covering BAH?+
Among analysts who currently cover BAH, Ronald Epstein of B of A Securities has the strongest overall Quantellect track record (Rank #47). Their current call is Sell with a $68.00 target.
What is Booz Allen Hamilton Holding's projected EPS for next quarter?+
The consensus estimate is $1.57 per share (range $1.47 – $1.66) across 13 analysts. Full-year EPS is projected at $6.62, rising to $6.75 the following year.
How much revenue is Booz Allen Hamilton Holding expected to report next quarter?+
Consensus revenue is $3.0B (range $2.9B – $3.1B). Full-year revenue is projected at $11.4B, growing to $11.9B next year.
Have analysts been upgrading or downgrading BAH lately?+
As of Nov 19, 2026, 3 of 11 active firms rate BAH a Buy (5 Neutral, 3 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BAH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.